Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Logan

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Rehab Management|February 22, 2007
Seeking relief. A variety of modalities is available for management of acute and chronic painCathy Logan
Rehab Management|August 5, 2008
Substantial solutions. Creating safe and sensitive care pathways for bariatric patientsCathy Logan
Rehab Management|September 5, 2008
The search for reliefCathy Logan
Rehab Management|November 30, 2006
Stimulating therapyCathy Logan
Rehab Management|March 21, 2007
Staying fit after 50Cathy Logan
Viruses|August 29, 2024
EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT OutcomesNancy Law, Cathy Logan, Randy Taplitz
Current Opinion in Infectious Diseases|July 11, 2023
Neutropenia and antibiotics: when, what, how and why?Jana Dickter, Cathy Logan, Randy Taplitz
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 3, 2016
Use of organs from donors with bloodstream infection, pneumonia, and influenza: Results of a survey of infectious diseases practitionersSanjay R Mehta, Cathy Logan, Camille N Kotton, et al.
Journal of the American Pharmacists Association : Japha|May 19, 2023
Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic reviewAryana Sepassi, Ila M Saunders, Mark Bounthavong, et al.
Pharmacoeconomics - Open|February 25, 2023
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United StatesAryana Sepassi, Ila M Saunders, Mark Bounthavong, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Rehab Management|February 22, 2007
Seeking relief. A variety of modalities is available for management of acute and chronic painCathy Logan
Rehab Management|August 5, 2008
Substantial solutions. Creating safe and sensitive care pathways for bariatric patientsCathy Logan
Rehab Management|September 5, 2008
The search for reliefCathy Logan
Rehab Management|November 30, 2006
Stimulating therapyCathy Logan
Rehab Management|March 21, 2007
Staying fit after 50Cathy Logan
Viruses|August 29, 2024
EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT OutcomesNancy Law, Cathy Logan, Randy Taplitz
Current Opinion in Infectious Diseases|July 11, 2023
Neutropenia and antibiotics: when, what, how and why?Jana Dickter, Cathy Logan, Randy Taplitz
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 3, 2016
Use of organs from donors with bloodstream infection, pneumonia, and influenza: Results of a survey of infectious diseases practitionersSanjay R Mehta, Cathy Logan, Camille N Kotton, et al.
Journal of the American Pharmacists Association : Japha|May 19, 2023
Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic reviewAryana Sepassi, Ila M Saunders, Mark Bounthavong, et al.
Pharmacoeconomics - Open|February 25, 2023
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United StatesAryana Sepassi, Ila M Saunders, Mark Bounthavong, et al.
Pageof 3